Tofidence Injection
Product Images NDC 64406-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tofidence (NDC 64406-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Ma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tofidence 01)

Figure 1 (Tofidence 01)
A line graph showing the percentage of ACE2 receptor presence (mean ± standard error) over various weeks (from week 2 to week 24) for three treatment groups: Placebo + MTX, ACTEMRA 8 mg/kg + MTX, and ACTEMRA 4 mg/kg + MTX. The x-axis represents the visit weeks, and the y-axis shows the percentage of ACE2 receptors, with values ranging from 0 to 100.*
FDA Label Image

Principal Display Panel (200 mg/10 mL Vial Carton)

Principal Display Panel (200 mg/10 mL Vial Carton)
Packaging label for Tofidence (tocilizumab-bavi) Injection, 200 mg/10 mL (20 mg/mL) single-dose vial for intravenous infusion after dilution. The label shows product information including drug name, strength, dosage form, route, storage instructions, manufacturer Biogen MA Inc, Cambridge, MA, and barcode details.*
FDA Label Image

Principal Display Panel (400 mg/20 mL Vial Carton)

Principal Display Panel (400 mg/20 mL Vial Carton)
Packaging label for Tofidence (tocilizumab-bavi) Injection, 400 mg/20 mL (20 mg/mL) for intravenous infusion after dilution. The label shows the product name, strength, dosage form, and storage instructions. It is manufactured by Biogen MA Inc., Cambridge, MA, USA, with the country of origin as China. The label also includes a barcode and QR codes with batch information.*
FDA Label Image

Principal Display Panel (80 mg/4 mL Vial Carton)

Principal Display Panel (80 mg/4 mL Vial Carton)
The packaging label for Tofidence (tocilizumab-bavi) injection shows a 80 mg/4 mL (20 mg/mL) solution for intravenous infusion. The label includes storage instructions to refrigerate at 2°C to 8°C and notes the product is preservative-free. It is manufactured by Biogen MA Inc., Cambridge, MA, and features dosing and disposal instructions for a single-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.